top of page
About us
A Noval Penetration Enhancer
CoR-Tech has, for the first time in nearly 200 years, demonstrated a novel ability to directly penetrate double membranes and access mitochondria, resulting in enhanced ATP and FAD production, as well as increased bioactivity. This achievement represents a significant advancement in direct cellular and organelle entry mechanisms.
US Patent No: 11273135 and more
HOW IT WORKS
CoR-Tech employs a novel polar solvent with unique negative charge properties to direct cellular entry. Serving as both a carrier and therapeutic agent, it enhances communication within cells and organelles via the mitochondrial pathway. CoR-Tech revolutionizes the drug industry by offering a simplified approach that surpasses nanotechnology in efficiency, safety, and efficacy.
OUR MISSION & VISION
Paving the way for a world where sickness is optional
We execute the segmental transfer of Biological Intelligence (CoR IP rights) through interested buyers, partnerships, or licensing.
bottom of page